Neuroendocrine differentiation in prostatic malignancy
Open Access
- 15 July 1996
- Vol. 78 (2) , 357-361
- https://doi.org/10.1002/(sici)1097-0142(19960715)78:2<357::aid-cncr27>3.0.co;2-u
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Review of Peptide Growth Factors in Benign Prostatic Hyperplasia and Urological MalignancyJournal of Urology, 1995
- Neuroendocrine differentiation in prostatic carcinoma. Recent findings and new conceptsCancer, 1995
- Cancer statistics, 1995CA: A Cancer Journal for Clinicians, 1995
- Overexpression of human epidermal growth factor receptor and c-erbB-2 by neuroendocrine cells in normal prostatic tissueUrology, 1994
- Parathyroid hormone-related protein is expressed by prostatic neuroendocrine cellsUrology, 1994
- Immunohistochemical localization of chromogranins A and B and secretogranin II in normal, hyperplastic and neoplastic prostateHistopathology, 1994
- Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinomaCancer, 1993
- Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implicationsCancer, 1992
- Neuro‐endocrine Cells—A New Prognostic Parameter in Prostate CancerBritish Journal of Urology, 1991
- Partial characterization of a thyroid‐stimulating hormone‐like peptide in neuroendocrine cells of the human prostate glandThe Prostate, 1989